Baxter International, Inc. (BAX)
25.70
+0.22
(+0.86%)
USD |
NYSE |
Sep 02, 16:00
25.60
-0.10
(-0.39%)
Pre-Market: 20:00
Baxter International Research and Development Expense (TTM) : 480.00M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 480.00M |
| March 31, 2026 | 489.00M |
| December 31, 2025 | 503.00M |
| September 30, 2025 | 518.00M |
| June 30, 2025 | 532.00M |
| March 31, 2025 | 528.00M |
| December 31, 2024 | 510.00M |
| September 30, 2024 | 506.00M |
| June 30, 2024 | 506.00M |
| March 31, 2024 | 541.00M |
| December 31, 2023 | 578.00M |
| September 30, 2023 | 607.00M |
| June 30, 2023 | 625.00M |
| March 31, 2023 | 608.00M |
| December 31, 2022 | 600.00M |
| September 30, 2022 | 577.00M |
| June 30, 2022 | 559.00M |
| March 31, 2022 | 550.00M |
| December 31, 2021 | 529.00M |
| September 30, 2021 | 528.00M |
| June 30, 2021 | 521.00M |
| March 31, 2021 | 500.00M |
| December 31, 2020 | 495.00M |
| September 30, 2020 | 516.00M |
| June 30, 2020 | 528.00M |
| Date | Value |
|---|---|
| March 31, 2020 | 551.00M |
| December 31, 2019 | 542.00M |
| September 30, 2019 | 554.00M |
| June 30, 2019 | 576.00M |
| March 31, 2019 | 599.00M |
| December 31, 2018 | 622.00M |
| September 30, 2018 | 638.00M |
| June 30, 2018 | 631.00M |
| March 31, 2018 | 621.00M |
| December 31, 2017 | 614.00M |
| September 30, 2017 | 585.00M |
| June 30, 2017 | 538.00M |
| March 31, 2017 | 539.00M |
| December 31, 2016 | 546.00M |
| September 30, 2016 | 552.00M |
| June 30, 2016 | 590.00M |
| March 31, 2016 | 582.00M |
| December 31, 2015 | 588.00M |
| September 30, 2015 | 584.00M |
| June 30, 2015 | 592.00M |
| March 31, 2015 | 769.00M |
| December 31, 2014 | 929.00M |
| September 30, 2014 | 1.142B |
| June 30, 2014 | 1.271B |
| March 31, 2014 | 1.202B |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Becton, Dickinson & Co. | 1.135B |
| DexCom, Inc. | 604.00M |
| Boston Scientific Corp. | 2.153B |
| West Pharmaceutical Services, Inc. | 74.40M |
| Abbott Laboratories | 3.128B |